Abiopharma

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule

V2X and Elastic Partner to Strengthen Search and Agentic Analytics Across Government Mission Workflows

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Almonty Completes Phase 1 of Sangdong Tungsten Mine in South Korea

SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions

A Message from Our Chief Executive Officer

Ferguson Files Definitive Proxy Materials and Transition Report

Enlight Secures $304 Million in Project Financing for the Crimson Orchard Project in Idaho, USA

Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager